Abstract
This chapter covers infections by Clostridioides (formerly Clostridium) difficile (C. difficile), Helicobacter pylori (H. pylori), Escherichia coli (E. coli), and conditions oropharyngeal candidiasis, gastroenteritis, Shigella colitis, Salmonella gastroenteritis, Campylobacter gastroenteritis, Whipple disease, Yersinia gastroenteritis, and infections by Vibrio cholerae, Listeria monocytogenes, Cryptosporidium hominis, Cyclospora cayetanensis, Epstein-Barr, cytomegalovirus, Herpes simplex, Helicobacter pylori. This chapter includes drug class, brand/trade names, manufacturer, dosage, indications, contraindications/cautions, adverse effects, drug interactions, pregnancy advice, lactation safety, relative cost of vancomycin, fidaxomicin, metronidazole, clarithromycin, amoxicillin, bismuth, metronidazole, tetracycline, levofloxacin, tinidazole, bactrim, azithromycin, erythromycin, doxycycline, tetracycline, penicillin G, hydroxychloroquine, fluconazole, voriconazole, caspofungin, clotrimazole nitzoxanide, ganciclovir, valganciclovir, foscarnet, tinidazole, albendazole, mebendazole, ivermectin, praziquantel, thiabendazole, pyrantel pamoate, tinidazole, paromomycin, iodoquinol, diethylcarbamazine, benznidazole, and triclabendazole. This chapter also includes a convenient algorithm for the treatment of Clostridioides difficile pseudomembranous colitis, and H. pylori, Whipple’s disease, and antihelminthic therapies.
Access provided by Autonomous University of Puebla. Download chapter PDF
Similar content being viewed by others
Keywords
- Clostridioides (formerly Clostridium) difficile (C. difficile)
- Helicobacter pylori (H. pylori)
- Escherichia coli (E. coli) gastroenteritis
- Shigella colitis
- Salmonella gastroenteritis
- Oropharyngeal candidiasis
- Whipple disease
- Campylobacter gastroenteritis
- Yersinia gastroenteritis
- Infections by Vibrio cholerae
- Listeria monocytogenes
- Cryptosporidium hominis
- Cyclospora cayetanensis
- Epstein-Barr
- Cytomegalovirus
- Herpes simplex
- Helicobacter pylori
- Vancomycin
- Fidaxomicin
- Metronidazole
- Clarithromycin
- Amoxicillin
- Bismuth
- Metronidazole
- Tetracycline
- Levofloxacin
- Tinidazole
- Bactrim
- Azithromycin
- Erythromycin
- Doxycycline
- Tetracycline
- Penicillin G
- Hydroxychloroquine
- Fluconazole
- Voriconazole
- Caspofungin
- Clotrimazole nitzoxanide
- Ganciclovir
- Valganciclovir
- Foscarnet
- Tinidazole
- Albendazole
- Mebendazole
- Ivermectin
- Praziquantel
- Thiabendazole
- Pyrantel pamoate
- Tinidazole
- Paromomycin
- Iodoquinol
- Diethylcarbamazine
- Benznidazole
- Triclabendazole
Clostridioides (formerly Clostridium) difficile Pseudomembranous Colitis
(See Fig. 7.1 for an algorithm for the treatment of Clostridioides difficile pseudomembranous colitis)
Vancomycin
Class: glycopeptide antibiotics
Brand name: Vancocin
Manufacturer: Pfizer
Dosage:
-
First-line agent in C. difficile pseudomembranous colitis
-
Non-severe or severe C. difficile infection: vancomycin 125 mg qid for 10 days
-
Severe: vancomycin 125 mg po qid ×10 d or fidaxomicin 200 mg po bid ×10 d
-
Fulminant: vancomycin 125 mg qid with iv metronidazole 500 mg iv q8h
Contraindications/cautions :
-
Hypersensitivity to vancomycin products
-
Caution if impaired renal function
-
Use with caution if hearing loss occurs
Adverse effects:
-
Gastrointestinal: nausea and vomiting
-
Cardiovascular: hypotension accompanied by flushing
-
Renal: nephrotoxicity (rare)
-
Hematologic: neutropenia (rare)
-
Immunologic: anaphylaxis (rare)
-
Dermatologic: erythematous rash on face and upper body (red neck or red man syndrome – infusion rate related)
-
Otic: ototoxicity (rare)
Drug interactions :
-
Increased nephrotoxicity with tenofovir, cidofovir, acyclovir, cyclosporine, ganciclovir
Pregnancy category: B
Lactation: probably safe
Relative cost: $$$$ (generic available: $–$$$)
Fidaxomicin
Class: macrolide antibiotics
Brand name: Dificid
Manufacturer: Merck
Dosing: recommended as alternative treatment option for pseudomembranous colitis
-
Initial episode: 200 mg po bid for 10 days
-
First recurrence: 200 mg po bid for 10 days
-
Second or subsequent recurrence: 200 mg po bid for 10 days
Contraindications/cautions:
-
Hypersensitivity reaction including angioedema, dyspnea
-
Caution if macrolide allergy
Adverse effects:
-
Gastrointestinal: nausea, abdominal distension, abdominal pain
-
Hepatic: increased liver enzymes (rare)
-
Hematologic : anemia (rare)
-
Dermatologic: pruritus, skin rash
Drug interactions:
-
Avoid combination with mizolastine, sodium picosulfate, cholera, and typhoid vaccines
Pregnancy category : B
Lactation: safety unknown
Relative cost: $$$
Metronidazole
(See Chap. 6 on General GI Infections)
Helicobacter pylori
Clarithromycin-based therapy
PPI + amoxicillin (1 g po bid), clarithromycin (500 mg po bid)
Bismuth quadruple therapy
PPI + metronidazole (500 mg po tid), tetracycline (500 mg po qid), bismuth subsalicylate or subcitrate (po qid)
Concomitant triple therapy
PPI + amoxicillin (1 g po bid), clarithromycin (500 mg po bid), metronidazole (500 mg po tid)
Amoxicillin
Class: penicillin antibiotics
Brand names: Amoxicot, Amoxil, Amoxil Pediatric Drops, Biomox, Dispermox, Trimox, Wymox
Manufacturer: Generic; Amoxil – GlaxoSmithKline; Dispermox – Ranbaxy; Trimox – Apothecon Inc.
Dosage: for H. pylori eradication : 1 g po bid in combination with PPI and other antibiotics. See table
Contraindications/cautions:
-
Hypersensitivity to amoxicillin
-
Infectious mononucleosis: risk of developing skin rash
-
Caution in phenylketonurics
-
Hypersensitivity to cephalosporins: risk of cross reactivity
Adverse effects:
-
Gastrointestinal: diarrhea, nausea, vomiting
-
Immunologic: immune hypersensitivity reaction
-
Dermatologic : rash
Drug interactions:
-
Typhoid vaccine, live oral: antibiotic may inactivate vaccine
Pregnancy category: B
Lactation: safe
Relative cost: $ (generic available: $)
Bismuth Subsalicylate
Class: anti-diarrheals
Brand name: Bismatrol, Pepto-Bismol
Manufacturer: Generic
Pharmacology: cytoprotectant
Dosage: H. pylori eradication: 262–524 mg po qid for 10–14 days in combination with PPI and other antibiotics
Contraindications/cautions :
-
G6PD deficiency
-
Coagulation disorder
-
Severe renal impairment
Adverse effects:
-
Fecal discoloration
-
Tongue discoloration
-
Constipation
-
Tinnitus
Pregnancy category: inadequate data to assess risk, possible risk of fetal harm
Lactation: safety unknown , considerate alternative
Clarithromycin
Class: macrolide antibiotics
Brand names: Biaxin, Biaxin Filmtab, Biazin XL
Manufacturer: generic; Biaxin – Abbott Laboratories
Dosage:
-
H. pylori eradication: 500 mg po bid in combination with PPI and other antibiotics. (See Table 7.1 for treatment of H. pylori)
Contraindications/cautions
-
Concomitant cisapride, pimozide, astemizole, terfenadine, ergotamine, or dihydroergotamine
-
Hypersensitivity to clarithromycin, erythromycin, or any macrolide antibiotics
-
Dose adjustment required in renal failure patients
Adverse effects:
-
Gastrointestinal: abdominal discomfort, abdominal pain, diarrhea, disorder of taste, indigestion, nausea, liver failure
-
Neurologic: headache
-
Immunologic: immune hypersensitivity reaction (severe), anaphylaxis, Stevens-Johnson syndrome, toxic epidermal necrolysis
Drug interactions:
-
phenothiazines, cisapride, dofetilide, pimozide, ranolazine: increase risk of QT prolongation and cardiac arrhythmias .
-
Ergot alkaloids: increase risk of ergot toxicity, severe vasospasm, and ischemia.
-
Eplerenone: risk of hyperkalemia
Pregnancy category: C
Lactation: possibly safe
Relative cost: $$ (generic available: $)
Levofloxacin
Class: fluoroquinolone antibiotics, inhibits DNA gyrase promoting breakage of DNA strands
Brand name: Levaquin
Manufacturer: Ortho-McNeil-Janssen Pharmaceuticals
Dosage: H. pylori eradication: 500 mg po qd in combination with PPI and other antibiotics. See table
Contraindications /cautions:
-
Hypersensitivity to FQs
-
Prior cardiac history or underlying QTc prolongation
-
In the elderly, concern for toxic psychosis and tendon rupture
-
Caution in people with G6PD deficiency and risk of hemolytic reactions
-
In patients with myasthenia gravis may increase muscle weakness
Adverse effects:
-
GI: nausea, diarrhea, constipation, abdominal pain, dyspepsia, vomiting
-
GU: vaginitis
-
CV: chest pain, edema
-
CNS: headache, insomnia, dizziness
-
Derm: skin rash, pruritus
Drug interactions :
-
Concomitant administration with other QtC-prolonging agents
-
Antacids may decrease absorption
Pregnancy category: C
Lactation: small amounts excreted in breast milk, consider cessation of drug or breastfeeding during administration
Relative cost: $$$ (generic available: $–$$)
Tinidazole
Class: imidazole derivative antibiotics
Brand name: Tindamax
Manufacturer: Mission Pharmacol Company
Pharmacology: causes cytotoxicity by damaging DNA and preventing further synthesis
Dosage: H. pylori eradication : 500 mg bid in combination with PPI and other antibiotics
Contraindications/cautions:
-
Hypersensitivity to nitroimidazole derivatives (including metronidazole)
Adverse effects:
-
CNS: fatigue, malaise, dizziness
-
GI: metallic taste, nausea, anorexia, flatulence, dyspepsia, vomiting, constipation
-
GU: pelvic pain, urine abnormality
-
MS: weakness
-
Respiratory: URI
Drug interactions:
-
Alcohol and disulfiram: result in toxic effects of disulfiram
Pregnancy category: C
Lactation: contraindicated in nursing mothers and 3 days after cessation of treatment
Relative cost : $$$ (generic available: $$–$$$)
E. coli (EP and EI) Gastroenteritis
-
Ciprofloxacin 500 mg po bid for 3–5 days
-
Bactrim 1 double strength tab po bid for 3–5 days
Shigella Colitis
-
Ciprofloxacin: drug of choice: 500 mg po bid for 3 days. If S. dysenteriae, extend therapy 5–7 days
-
Bactrim: 1 double strength tab (160 mg trimethoprim (TMP)/800 mg sulfamethoxazole (SMX)) po bid for 5 days
-
Azithromycin: 500 mg po qd for 1 days, then 250 mg po qd for 3 days
Salmonella Gastroenteritis
-
1.
Usually symptomatic management with fluids and electrolyte replacement
-
2.
In severely ill, immunocompromised adults and children or elderly patients:
-
Ciprofloxacin 500 mg po bid for 3–7 days or
-
Levofloxacin 500 mg po qd or
-
Trimethoprim-sulfamethoxazole 160 mg/800 mg po bid or
-
Amoxicillin 500 mg po tid or
-
If intravenous therapy were required: a third-generation cephalosporin (ceftriaxone 1 to 2 g iv qd or cefotaxime 2 g iv q8h)
-
Campylobacter Gastroenteritis
-
1.
Usually symptomatic management with fluids and electrolyte replacement
-
2.
In severely ill, elderly, pregnant, or immunocompromised patients, and those with bloody stools, high fever, extraintestinal infection, worsening or relapsing symptoms, or symptoms lasting longer than 1 week
-
Azithromycin 500 mg po qd for 3 days or
-
Ciprofloxacin 750 mg po bid for 3 days
-
Vibrio cholerae
-
1.
Usually management with fluids and electrolyte replacement either orally or intravenously
-
2.
As adjunct to appropriate rehydration
-
Tetracycline500 mg po qid for 3 days or
-
Doxycycline 300 mg once or
-
Erythromycin 500 mg po qid for 3 days or
-
Azithromycin 1000 mg po once or
-
Ciprofloxacin 1000 mg po once
-
Yersinia Gastroenteritis
-
1.
Usually symptomatic management with fluids and electrolyte replacement
-
2.
In severely ill, elderly, pregnant, or immunocompromised patients, or those having an underlying comorbid illness
-
Ciprofloxacin 500 mg bid for 5 days or
-
Trimethoprim-sulfamethoxazole in children (TMP 8 mg/kg/d and SMX 40 mg/kg/d bid
-
If septicemia: ceftriaxone 2 g/d combined with gentamicin 5 mg/kg/d in qd to tid for 3 weeks
-
Listeria monocytogenes
Isolated gastrointestinal illness does not require antibiotic treatment
Trimethoprim-Sulfamethoxazole
(See Chap. 6)
Ciprofloxacin
(See Chap. 6)
Whipple Disease
(See Table 7.2 for treatment of Whipple disease)
Azithromycin
Class: macrolide antibiotics
Brand name: Zithromax
Manufacturer: Pfizer, Inc.
Dosage:
-
Shigella and enterohemorrhagic E. coli: 500 mg po qd for 3 days
Contraindications/cautions:
-
Hypersensitivity to drug or components
-
Use with caution in impaired renal function, impaired hepatic function
-
Use with caution in QT prolongation
Adverse effects:
-
Gastrointestinal: cholestatic jaundice, pseudomembranous colitis, diarrhea, nausea, abdominal pain, dyspepsia
-
Cardiovascular: QT prolongation
-
Dermatologic : angioedema, Stevens-Johnson syndrome, pruritus
Drug interactions:
-
Increased risk of QT prolongation with cisapride, phenothiazines, pimozide, ranolazine, antiarrhythmics class IA and class III, chloroquine, droperidol, haloperidol, erythromycin, flecainide, methadone, pentamidine, ziprasidone
Pregnancy category: B
Lactation: enters breast milk/use caution
Relative cost : $$$ (generic available: $–$$)
Erythromycin
Class: macrolide antibiotics
Brand name: E-mycin
Manufacturer: Abbott
Dosage:
-
250–500 mg po q6 to q12h
Contraindications/cautions:
-
Hypersensitivity to drug or components
Adverse effects :
-
Gastrointestinal: abdominal pain, anorexia, pancreatitis, pseudomembranous colitis, diarrhea
-
Cardiovascular: QT prolongation, torsade de pointes, ventricular arrhythmia
-
Otic: hearing loss
Drug interactions:
-
Substrate of CYP2B6 and CYP3A4, P-glycoprotein, Inhibits CYP1A2, CYP3A4, P-glycoprotein
Pregnancy category: B
Lactation: enters breast milk/use caution
Relative cost: $ (generic available: $)
Doxycycline
Class: natural and semi-synthetic tetracycline antibiotics
Brand names: Adoxa, Doryx, Doxy Lemmon, Doxy-Caps, Doxy-D, Monodox, Oracea, Periostat, Vibra-Tabs, Vibramycin, Vibramycin Calcium, Vibramycin Hyclate, Vibramycin Monohydrate
Manufacturer: generic
Dosage:
-
Vibrio cholerae – 300 mg po one dose
Contraindications/cautions:
-
Hypersensitivity to drug or components
-
Children less than 8 years old
-
Caution in impaired liver function, impaired renal function
-
Avoid sun/UV light exposure
-
Caution if history of, or predisposition to, candidiasis
-
Pregnancy
Adverse effects:
-
Dermatologic: photosensitivity, skin discoloration, rash, erythema multiforme, Stevens-Johnson syndrome
-
Gastrointestinal: hepatotoxicity, esophagitis, pseudomembranous colitis, pancreatitis, diarrhea, nausea, dyspepsia
-
Hematologic: neutropenia, thrombocytopenia, hemolytic anemia
-
Other: tooth discoloration in children less than 8 years old, headache, joint pain, pericarditis
Drug interactions:
-
Contraindicated with acitretin due to increased risk of pseudotumor cerebri and papilledema
-
Increased levels and risk of digoxin, lithium toxicity if given together
-
Increased phototoxicity with hydroquinone/retinoic acid combinations
Pregnancy category: D
Lactation: unsafe
Relative cost: $ (generic available: $)
Tetracycline
Class: natural and semi-synthetic tetracycline antibiotics
Brand name: Sumycin
Manufacturer: generic
Dosage: 1 to 2 g/d po bid-qid. Give at least 1 h before or 2 h after meals
Contraindications/cautions:
-
Hypersensitivity to drug or components
-
Use with caution in impaired renal function, impaired hepatic function
-
Use with caution in systemic lupus erythematosus
-
Pregnancy
Adverse effects:
-
Gastrointestinal: hepatotoxicity, pseudomembranous colitis, pancreatitis, diarrhea, nausea, dyspepsia, abdominal discomfort
-
Hematologic: neutropenia, thrombocytopenia, hemolytic anemia
-
Dermatologic: photosensitivity, skin discoloration, rash, erythema multiforme, Stevens-Johnson syndrome
-
Other: tooth discoloration in less than 8 years old, headache, dizziness
Drug interactions:
-
Contraindicated with acitretin due to increased risk of pseudotumor cerebri and papilledema
-
Increased levels and risk of digoxin, lithium toxicity if given together
-
Increased phototoxicity with hydroquinone/retinoic acid combinations
Pregnancy category: D
Lactation: possibly unsafe
Relative cost: $ (generic available: $)
Fungal Infections
Oropharyngeal candidiasis
-
1.
HIV negative patients:
Topical therapy, with either clotrimazole troches (10 mg troche five times daily) or nystatin suspension (400,000 to 600,000 units qid)
-
2.
HIV positive patients:
For initial episode of oropharyngeal candidiasis in HIV-infected patients with mild disease – topical therapy
-
3.
For patients with recurrent infection, moderate to severe disease, or in those with advanced immunosuppression (CD4 < 100) – fluconazole 200 mg loading dose, followed by 100 to 200 mg qd for 7 to 28 days
Esophageal Candidiasis
-
Fluconazole 400 mg loading dose followed by 200–400 mg po qd for 14 to 28 days
-
Voriconazole 200 mg po bid for 14 to 28 days
-
If iv therapy needed – caspofungin 50 mg intravenously for 7–21 days
-
Clotrimazole 10 mg troche five times daily for 7–14 days
Fluconazole
Class: azole antifungals
Brand name: Diflucan
Manufacturer: Pfizer, Inc.
Dosage:
-
Esophageal candidiasis: Loading dose of 400 mg po/iv on day 1, then 200 to 400 mg po qd for 14–21 days
Contraindications/cautions:
-
Hypersensitivity to drug or components
-
Caution in impaired liver function, renal function
-
Caution in QT prolongation, pro-arrhythmic conditions, electrolyte abnormalities, heart disease, elderly
Adverse effects:
-
Gastrointestinal : hepatotoxicity, nausea, vomiting, abdominal pain, diarrhea, dyspepsia, taste changes
-
Neurologic: seizures, headache, dizziness
-
Cardiac: QT prolongation, torsades de pointes
-
Hematologic: leucopenia, agranulocytosis, thrombocytopenia
-
Dermatologic: Stevens-Johnson syndrome, angioedema, rash
Drug interactions:
-
Decreased levels of antifungal drug with concomitant use of barbiturates, carbamazepine, rifampin, rifabutin
-
Increased risk of QT prolongation with cisapride, droperidol, phenothiazines, pimozide, quinidine, ranolazine, amiodarone
Pregnancy category: C
Lactation: probably safe
Relative cost: $$$ (generic available: $–$$$)
Voriconazole
Class: azole antifungals
Brand name: Vfend
Manufacturer: Pfizer, Inc.
Dosage:
-
Esophageal candidiasis: 200 mg po q12h. Treat for 14 days minimum and for 7 days after symptom resolution. Give 1 h before or after meal
Contraindications/cautions:
-
Hypersensitivity to drug or components
-
Caution in impaired liver function, renal function
-
Caution in proarrhythmic conditions, electrolyte abnormalities, galactose intolerance, lactase deficiency, hematologic malignancy
Adverse effects:
-
Gastrointestinal: hepatitis, fulminant hepatic failure, nausea, vomiting, diarrhea, abdominal pain, increase in liver transaminases, increase in alkaline phosphatase
-
Cardiac: QT prolongation, torsades de pointes, tachycardia
-
Dermatologic: Stevens-Johnson syndrome, angioedema, rash
-
Other: color vision changes, photophobia, hallucinations, renal failure, peripheral edema
Drug interactions:
-
Decreased levels of antifungal drug with concomitant use of barbiturates, carbamazepine, rifampin, rifabutin
-
Increased risk of QT prolongation with cisapride, droperidol, phenothiazines, pimozide, quinidine, ranolazine, amiodarone
Pregnancy category: D
Lactation: safety unknown
Relative cost: $$$$ (generic available: $$–$$$)
Caspofungin
Class: echinocandins antifungals
Brand name: Cancidas
Manufacturer: Merck & Co., Inc.
Dosage:
-
Esophageal candidiasis: 50 mg iv q24h for 7–21 days
Contraindications/cautions:
-
Hypersensitivity to drug or components
-
Caution in impaired liver function
Adverse effects:
-
Gastrointestinal: hepatotoxicity, nausea, vomiting, diarrhea, abdominal pain, increase in liver enzymes, increase in alkaline phosphatase
-
Pulmonary: adult respiratory distress syndrome, pulmonary edema
-
Other: fever, chills, infusion-related reaction, hypercalcemia, hypokalemia, flushing, eosinophilia
Drug interactions:
-
Cyclosporine may increase caspofungin levels and risk of hepatotoxicity
-
Carbamazepine, dexamethasone, efavirenz, nevirapine, phenytoin, rifabutin, rifampin may decrease caspofungin levels
-
Caspofungin may decrease sirolimus, tacrolimus levels
Pregnancy category: C
Lactation: safety unknown
Relative cost: $$$$$
Clotrimazole
Class: antifungals
Brand name: Mycelex Troche
Manufacturer: Janssen Pharmaceuticals
Dosage :
-
Esophageal candidiasis: 10 mg troche five times daily for 7–14 days
Contraindications/cautions:
-
Hypersensitivity to drug or components
Adverse effects:
-
Gastrointestinal: abnormal liver function
Drug interactions:
-
Avoid concomitant use with tolvaptan
Pregnancy category: C
Lactation: safety unknown
Relative cost: $$$ (generic available: $–$$)
Cryptosporidium hominis
-
Nitzoxanide 500 mg po bid for 7 days
See below for product details
Cyclospora cayetanensis
-
Bactrim 160/800 mg po bid for 7 days
(See Chap. 6 for more drug details)
Nitazoxanide
Class: agents for amoebiasis
Brand name: Alinia
Manufacturer: Romark Laboratories, LC
Dosage:
-
Infectious diarrhea: 500 mg po q12h for 3 days. Give with food
-
Cryptosporidium hominis: 500 mg po bid for 7 days
Contraindications/cautions :
-
Hypersensitivity to drug or components
-
Caution in impaired liver function, renal function
-
Caution in biliary disease, diabetes, HIV, immunodeficiency
Adverse effects:
-
Gastrointestinal: abdominal pain, diarrhea, nausea
-
Other: headache
Drug interactions:
-
May increase levels of warfarin and phenytoin
Pregnancy category: B
Lactation: safety unknown
Relative cost: $$$
Viral Infections
Cytomegalovirus (CMV)
-
Gastrointestinal disease
-
Ganciclovir (5 mg/kg po bid) or foscarnet (90 mg/kg po bid) for induction therapy for 3–6 weeks
-
Switch to oral valganciclovir (900 mg bid) to complete induction therapy when presenting clinical manifestations have resolved.
-
-
Hepatitis
-
Usually self-limited course. In severe CMV hepatitis, ganciclovir or valganciclovir has been recommended. Consider liver transplant evaluation in fulminant disease
-
Herpes Simplex (HSV)
-
Gastrointestinal disease
-
Acyclovir 400 mg po tid for 14 to 21 days. In immunocompromised individuals: 400 mg po five times a day for 14 to 21 days
-
If unable to swallow – acyclovir 5 mg/kg iv q8h for 7 to 14 days or iv foscarnet 40 mg/kg/dose every 8–12 h for 14–21 days
-
-
Hepatitis
-
Acyclovir 10 mg/kg iv q8h for up to 21 days for any HSV hepatitis or in cases of severe disseminated disease
-
Epstein Barr Virus (EBV) Hepatitis
-
Usually self-limited course. In severe cases, consider antiviral therapy with either acyclovir or ganciclovir (optimal dosing and duration undefined). Consider corticosteroid therapy and evaluation for liver transplantation in cases of severe fulminant hepatitis
Ganciclovir
Class: nucleoside and nucleotide DNA polymerase inhibitor antivirals
Brand name: Cytovene
Manufacturer: Roche Laboratories
Dosage:
-
CMV prophylaxis in solid organ transplant: 5 mg/kg iv q12h for 7–14 days, then 5 mg/kg iv q24h × 1 week or 6 mg/kg q24h 5 times/week. Alternative: 1000 mg po tid. Give with food
-
CMV gastrointestinal disease: 5 mg/kg iv bid × 3–6 weeks for induction therapy
Contraindications /cautions:
-
Hypersensitivity to drug or components
-
Hypersensitivity to acyclovir
-
Absolute neutrophil count less than 500
-
Platelets less than 25,000
-
Caution in impaired renal function
-
Caution in myelosuppression, elderly
Adverse effects:
-
Gastrointestinal: pancreatitis, perforation, diarrhea, vomiting, increased liver transaminases
-
Neurologic: seizures, neuropathy
-
Hematologic: pancytopenia, anemia
-
Other: depression, retinal detachment, hypertension, nephrotoxicity, impaired fertility, fever
Drug interactions :
-
Increased risk of nephrotoxicity with cidofovir, aminoglycosides, carboplatin, cisplatin, clofarabine, efavirenz/emtricitabine/tenofovir, tacrolimus
-
Increased risk of myelosuppression with clozapine, azathioprine, cisplatin, methotrexate
-
Increased risk of seizures with imipenem
Pregnancy category: C
Lactation: unsafe
Relative cost: $$$
Valganciclovir
Class: nucleoside and nucleotide DNA polymerase inhibitor antivirals
Brand name: Valcyte
Manufacturer: Roche Laboratories
Dosage:
-
CMV colitis: 900 mg po bid for 21–42 days
Contraindications/cautions:
-
Hypersensitivity to drug or components
-
Hypersensitivity to ganciclovir
-
Absolute neutrophil count less than 500
-
Hemoglobin less than 8 mg/dl
-
Platelets less than 25,000
-
Caution in impaired renal function
-
Caution in myelosuppression, elderly, chemotherapy, pregnancy
Adverse effects:
-
Gastrointestinal: diarrhea, vomiting, abdominal pain
-
Neurologic: seizures, neuropathy, agitation, psychosis
-
Hematologic : aplastic anemia, leucopenia, thrombocytopenia, neutropenia, myelosuppression
-
Other: infertility, nephrotoxicity
Drug interactions:
-
Increased risk of nephrotoxicity with cidofovir, aminoglycosides, carboplatin, cisplatin, clofarabine, efavirenz/emtricitabine/tenofovir, tacrolimus
-
Increased risk of myelosuppression with clozapine, azathioprine, cisplatin, methotrexate
-
Increased risk of seizures with imipenem
Pregnancy category: C
Lactation: unsafe
Relative cost: $$$$$
Foscarnet
Class: non-nucleoside DNA polymerase inhibitor antivirals
Brand name: Foscavir
Manufacturer: Clinigen Group plc
Dosage:
-
CMV colitis: 60 mg/kg po q8h or 90 mg/kg q12h for 3–6 weeks
Contraindications/ cautions:
-
Hypersensitivity to drug or components
-
Caution in impaired renal function.
-
Caution in myelosuppression, seizure, cardiac disease, electrolyte abnormalities, combination with nephrotoxic agents
Adverse effects:
-
Gastrointestinal: pancreatitis, nausea, vomiting, diarrhea
-
Neurologic: paresthesias
-
Hematologic: anemia, granulocytopenia, leukopenia, thrombocytopenia
-
Other: hypomagnesemia, hypokalemia, hypocalcemia, nephrotoxicity, fever
Drug interactions:
-
Increased nephrotoxicity with cidofovir, aminoglycosides, carboplatin, cisplatin, clofarabine, efavirenz/emtricitabine/tenofovir, gallium, tenofovir
-
May cause QT prolongation with droperidol, erythromycin, amiodarone
Pregnancy category: C
Lactation: safety unknown
Relative cost: $$$$$
Protozoan Infections
Antihelminthic Therapies
(See Table 7.3 for antihelminthic therapies)
Amebiasis
-
1.
To eliminate intraluminal infection
-
500 to 750 mg po tid for 7 to 10 days
-
Tinidazole 2 g po qd for 3 days
-
-
2.
To eliminate intraluminal encysted organisms
-
Paromomycin: 25–30 mg/kg/day po tid for 7 days
-
Giardiasis
-
Treatment of choice: tinidazole po 2 g single dose
-
Alternative agents: Nitazoxanide 500 mg po bid for 3d. Metronidazole 250 mg po tid for 5d
Parasitic Infestations
Angiostrongyliasis
-
Supportive and corticosteroids
Ascariasis (A. lumbricoides)
-
Treatment of choice: mebendazole 100 mg po bid for 3 days
-
Alternative treatments: pyrantel pamoate 11 mg/kg or albendazole 400 mg once
Cutaneous Larva Migrans
-
Treatment of choice: ivermectin 200 μg/kg po qd for 1–2 days
-
Alternative treatments: albendazole 400 mg po qd for 3 days
Cysticercosis (Taenia solium)
-
Treatment of choice: albendazole 15 mg/kg/day po bid for 10–14 days
-
Alternative treatments: praziquantel 50 mg/kg/day po tid for 10–14 days
-
Concurrent steroids for CNS disease
Dracunculiasis (Guinea Worm Disease)
-
Metronidazole 250 mg po tid for 10 days plus worm removal
Echinococcosis (Hydatid Cyst)
-
Treatment of choice: perioperative albendazole followed by surgery
-
Alternative treatments: albendazole 400 mg po bid for 1–6 months
Enterobiasis (Pinworm)
-
Pyrantel pamoate 11 mg/kg po once
-
Albendazole 400 mg po once
-
Mebendazole 100 mg po once
-
Repeat after 2 weeks
Hook Worm (Ancylostomiasis)
-
Albendazole 400 mg po once or
-
Mebendazole 100 mg po bid for 3 days or
-
Pyrantel pamoate 11 mg/kg po for 3 days
Lymphatic Filariasis (W. bancrofti, B. malayi, B. timori)
-
Diethylcarbamazine 6 mg/kg po once
Loaisis (M. streptocerca, O. volvulus, D. medinensis)
-
Diethylcarbamazine 8 to 10 mg/kg/day po tid for 21 days
Tropical Pulmonary Eosinophilia
-
Diethylcarbamazine 6 mg/kg/day po tid for 14–21 days
Trypanosoma cruzi (Chagas Disease)
-
Benznidazole for acute infection only: 5 to 7 mg/kg/day po bid for 60 days
Onchocerciasis (River Blindness)
-
Ivermectin 150 μg/kg po once; repeat every 6–12 months
Fluke Infections
-
Liver flukes (Clonorchis sinensis), intestinal flukes (Fasciolopsis buski): praziquantel 25 mg/kg/d po tid for 1 day
-
Lung fluke (Paragonimus westermani): praziquantel 25 mg/ kg/day po tid for 2 days
-
Sheep liver fluke: triclabendazole 10 mg/kg po once
Schistosomiasis
-
S. mansoni, S. haematobium: praziquantel 40 mg/kg/d po in bid × 1 day
-
S. japonicum, S. mekongi: praziquantel 60 mg/kg/d po in tid × 1 day
Strongyloidiasis
-
Treatment of choice: ivermectin 200 μg/kg/d po for 2 d. If immunocompromised 200 μg/kg/d po for 2 days and repeat at 2 weeks
-
Alternative treatments: albendazole 400 mg po qd for 3–7 days.
Tapeworm Intestinal Infections (Taenia saginata)
-
Praziquantel 5–10 mg/kg po for 1 day
Trichinellosis (Roundworm)
-
Treatment of choice: steroids for severe symptoms plus mebendazole 200–400 mg po tid for 3 days, then 400–500 mg po tid for 10 days
-
Alternative treatments: albendazole 400 mg po bid for 10–14 days
Trichuriasis (Whipworm)
-
Treatment of choice: mebendazole 100 mg po bid for 3 days or albendazole 400 mg po qd for 3 days
-
Alternative treatments: ivermectin 200 Μg/kg/day po for 3 days
Albendazole
Class: antinematodal agents, benzimidazole
Brand name: Albenza
Manufacturer: GlaxoSmithKline, generic
Dosages:
-
Ancylostomiasis and necatoriasis: 400 mg po as a single dose
-
Ascariasis: 400 mg po as a single dose
-
Clonorchiasis: 10 mg/kg po qd for 7 days
-
Cutaneous larva migrans: 400 mg po qd for 3 days
-
Echinococcus granulosus infection, hydatid disease: 60 kg or greater, 400 mg po bid for three 28-day cycles
-
Enterobiasis: 400 mg po as a single dose; repeat in 2 weeks
-
Enterocolitis, eosinophilic – infection by Ancyclostoma caninum: 400 mg po as a single dose
-
Infection by Gnathostoma: 400 mg po bid for 21 days
-
Infection by Microsporidia: intestinal due to E. intestinalis, 400 mg po bid for 21 days
Contraindications:
-
Hypersensitivity to albendazole or benzimidazole products
-
Pregnancy
-
Use with caution in impaired liver function
Adverse effects:
-
Gastrointestinal: abdominal pain, nausea, vomiting, hepatotoxicity
-
Neurologic: headache
-
Renal: acute renal failure (rare)
-
Hematologic: agranulocytosis, granulocytopenia, leukopenia, pancytopenia, thrombocytopenia (rare)
Drug interactions:
-
Increased risk of albendazole toxicity with praziquantel and dexamethasone
Pregnancy category: C
Lactation: safe
Relative cost: $$$
Mebendazole
Class: antinematodal agents, benzimidazole
Brand name: Emverm
Manufacturer: Impax Laboratories, Inc.
Dosages:
-
Ancylostomiasis and necatoriasis: 100 mg po bid for 3 days
-
Ascariasis: 100 mg po bid for 3 days
-
Enterobiasis: 100 mg po once
-
Trichuriasis: 100 mg po bid for 3 days
*treatment may be repeated in 3 weeks in all above conditions
Contraindications/cautions:
-
Hypersensitivity to mebendazole products
-
Caution if prolonged use
Adverse effects:
-
Gastrointestinal: abdominal pain, diarrhea, hepatitis
-
Neurologic: headache, seizure
-
Dermatologic: rash, angioedema
-
Hematologic: neutropenia, agranulocytosis
Drug interactions: No significant drug interactions
Pregnancy category: C
Lactation: safe
Relative cost: $$$
Ivermectin
Class: antinematodal agents
Brand name: Stromectol
Manufacturer: Merck & Co., Inc.
Dosages:
-
Infection by Onchocerca volvulus: 150 μg/kg, single oral dose; retreatment interval between 3 and 12 months. Give on empty stomach
-
Intestinal strongyloidiasis: 200 μg/kg, single oral dose
Contraindications/cautions:
-
Hypersensitivity to ivermectin or components
-
Pregnancy
-
Asthma
Adverse effects:
-
Gastrointestinal: disease of gastrointestinal tract, nausea, vomiting, diarrhea
-
Neurologic: dizziness, headache
-
Dermatologic: pruritus
Drug interactions: no significant drug interactions
Pregnancy category: C
Lactation: safety unknown
Relative cost: $$ (generic available: $$)
Praziquantel
Class: antitrematodal agents
Brand name: Biltricide
Manufacturer: Bayer
Indications:
-
Schistosomiasis: 20 mg/kg po tid for 1 day
-
Clonorchiasis: 25 mg/kg po tid for 1 day
-
Tapeworms: 5–25 mg/kg po once
-
Intestinal flukes: 25 mg/kg po tid for 1 day
Contraindications/ cautions:
-
Hypersensitivity to praziquantel
-
Ocular cysticercosis
-
History of seizures
Adverse effects:
-
Gastrointestinal: abdominal pain
-
Cardiovascular: cardiac dysrhythmia, heart block
-
Neurologic: dizziness, headache, seizure
-
Other: malaise
Drug interactions :
-
Chloroquine may decrease praziquantel levels
-
Combination may increase albendazole levels
Pregnancy category: B
Lactation: Avoid breastfeeding for 3 days after last dose
Relative cost: $$$
Thiabendazole : No Longer Available in the USA
Class: antinematodal agents, benzimidazole
Brand name: Mintezol
Manufacturer: Merck & Co., Inc.
Dosages:
-
Ascariasis: (not first-line therapy): 50 mg/kg/d q12 h po for 2 days
-
Cutaneous larva migrans – for 2 days
-
Visceral larva migrans – for 7 days
-
Trichinosis – for 2–3 days
-
Dracunculosis – for 3 days
Contraindications /cautions:
-
Hypersensitivity to thiabendazole products
-
Prophylactic treatment of pinworm infestation
Adverse effects:
-
Gastrointestinal: nausea, vomiting, anorexia, diarrhea, hepatotoxicity
-
Neurologic: central nervous system finding, dizziness, drowsiness
-
Dermatologic: erythema multiforme, Stevens-Johnson syndrome
Drug interactions:
-
Combination may increase theophylline levels and risk of toxicity
Pregnancy category: C
Lactation: safety unknown
Relative cost: $
Pyrantel Pamoate
Class: antinematodal agents
Brand name: Ascarel, Pamix, Pin-X
Manufacturer: generic
Dosages:
-
Enterobiasis: 11 mg/kg (up to maximum 1 gm) po once
-
Ascariasis: 11 mg/kg (up to maximum 1 gm) po once
Contraindications /cautions:
-
Hypersensitivity to drug
-
Pregnancy
-
Liver disease
Adverse effects:
-
Gastrointestinal: abdominal discomfort, nausea, vomiting
-
Neurologic: dizziness, headache, somnolence
Drug interactions: no major drug interactions
Pregnancy category: generally regarded as unsafe
Lactation: safety unknown
Relative cost : $ (generic available: $)
Tinidazole
Class: imidazole derivative antibiotics
Brand name: Tindamax
Manufacturer: Mission Pharmacal Company
Dosages:
-
Intestinal amebiasis: 2000 mg po qd for 3 days
-
Amebic liver abscess: 2000 mg po qd for 3–5 days
-
Giardiasis: 2000 mg po once. Give with food
Contraindications /cautions:
-
Hypersensitivity to drug or components
-
Caution in impaired liver function
-
Caution in disulfiram use, alcohol use, CNS disorder, blood dyscrasia
Adverse effects:
-
Gastrointestinal: candidiasis, nausea, vomiting
-
Neurologic: seizures, peripheral neuropathy
-
Pulmonary /: bronchospasm
-
Hematologic: thrombocytopenia
-
Dermatologic: Stevens-Johnson syndrome, erythema multiforme
-
Other: menorrhagia
Drug interactions:
-
Disulfiram like reaction with alcohol, lopinavir/ritonavir, tipronavir, diazoxide, ethanol
-
May increase levels of lithium, phenytoin, cyclosporine, tacrolimus
Pregnancy category: C
Lactation: avoid / breastfeeding during treatment and for 72 h after discontinuation. No human data available to assess risk of infant harm
Relative cost: $$$ (Generic available: $$)
Paromomycin
Class: aminoglycoside antibiotics
Brand name: Humatin
Manufacturer: King Pharmaceuticals, Inc.
Dosages:
-
Intestinal amebiasis : 25–35 mg/kg/day po divided in tid for 5–10 days
-
Hepatic encephalopathy: 1000 mg po qid for 5–6 days
-
Cryptosporidial diarrhea in HIV: 1500–3000 mg po divided 3–6 times per day. Alternative: 1000 mg po bid × 12 weeks in combination with azithromycin 600 mg po qd for 4 weeks. Give with food
Contraindications/cautions:
-
Hypersensitivity to drug or components
-
Use with caution in impaired renal function
-
Use with caution in intestinal obstruction, inflammatory bowel disease, neurotoxic agents, ototoxic agents , dehydration, neuromuscular disease, auditory or vestibular dysfunction
Adverse effects:
-
Gastrointestinal: malabsorption syndrome (prolonged use), enterocolitis, nausea, abdominal cramps, diarrhea
-
Other: nephrotoxicity, ototoxicity, neurotoxicity
Drug interactions:
-
Increased risk of nephrotoxicity with acyclovir, aminoglycoside, cyclosporine, flucytosine, foscarnet, ganciclovir, mitomycin, penicillamine, sirolimus, vancomycin
Pregnancy category: C
Lactation: probably safe
Relative cost : $$$ (generic available: $$$)
Iodoquinol
Class: antifungals
Brand name: Yodoxin
Manufacturer: Glenwood, LLC
Dosage:
-
Intestinal amebiasis: 650 mg po tid for 20 days. Give after meals, repeat treatments should be performed in 2–3-week intervals
Contraindications /cautions:
-
Hypersensitivity to drug or components
-
Hypersensitivity to iodine
-
Use with caution in hepatic dysfunction
-
Use with caution in thyroid disease
Adverse effects:
-
Gastrointestinal: nausea, vomiting, abdominal pain
-
Dermatologic: pruritus, skin discoloration
-
Other: optic neuritis, peripheral neuropathy, headache
Drug interactions :
-
Inadequate immunologic response to concomitant live oral typhoid vaccine
-
May decrease levels of mycophenolate mofetil
Pregnancy category: C
Lactation: safety unknown
Relative cost: $$$$$
Diethylcarbamazine
Class: antihelminthics
Brand name: Hetrazan
Manufacturer: Wyeth
Dosage:
-
Loiasis: 8 to 10 mg/kg/day po tid for 21 days
-
Lymphatic filariasis: 6 mg/kg/day po qd or tid for 12 days
Contraindications /cautions:
-
Hypersensitivity to drug or components
Adverse effects:
-
Neurologic: encephalopathy
-
Gastrointestinal: nausea
Drug interactions :
-
Inadequate studies
Pregnancy category: X
Lactation: breast milk excretion unknown
Relative cost: $$$
Benznidazole
Class: agents for leishmaniasis and trypanosomiasis
Brand name: Rochagan
Manufacturer: Brazilian Government (not commercially available in the USA)
Dosage:
-
Chagas disease: 5 to 7 mg/kg/day po bid for 60 days
Contraindications /cautions:
-
Hypersensitivity to drug or components
Adverse effects:
-
Neurologic: convulsions, seizures, peripheral neuropathy
Drug interactions:
-
Enhance toxic effect of disulfiram
Pregnancy: avoid using during pregnancy; possible risk of fetal harm
Lactation: breastfeeding during therapy not recommended
Relative cost: $
Triclabendazole
Class: benzimidazole antihelminthics
Brand name: Egaten
Manufacturer: Novartis
Dosage:
-
Fascioliasis: 10 mg/kg po q12h for 2 doses
Contraindications/cautions:
-
Hypersensitivity to drug or components
Adverse effects:
-
Gastrointestinal: self-limited biliary obstruction, abdominal cramping
Drug interactions:
-
No known interactions
Pregnancy category: B
Lactation: safety unknown
Relative cost: $$$
Suggested Reading
McDonald LC, Gerding DN, Johnson S, et al. Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis. 2018;66(7):e1–e48.
Chey WD, Leontiadis GI, Howden CW, et al. ACG clinical guideline: of Helicobacter pylori infection. Am J Gastroenterol. 2017;112(2):212–39.
Cdc.gov. https://www.cdc.gov/parasites/index.html. Accessed 1 Dec 2021.
Samuel D. Cytomegalovirus infection, fulminant hepatitis, and liver transplantation: the sides of the triangle. Liver Transpl. 1997;3(5):552–5.
Norvell JP, Blei AT, Jovanovic BD, Levitsky J. Herpes simplex virus hepatitis: an analysis of the published literature and institutional cases. Liver Transpl. 2007;13(10):1428–34.
Bennish ML, Salam MA, Khan WA, Khan AM. Treatment of shigellosis: III. Comparison of one- or two-dose ciprofloxacin with standard 5-day therapy. A randomized, blinded trial. Ann Intern Med. 1992;117(9):727–34.
Onwuezobe IA, Oshun PO, Odigwe CC. Antimicrobials for treating symptomatic non-typhoidal Salmonella infection. Cochrane Database Syst Rev. 2012;11:CD001167.
Dryden MS, Gabb RJ, Wright SK. Empirical treatment of severe acute community-acquired gastroenteritis with ciprofloxacin. Clin Infect Dis. 1996;22(6):1019–25.
White AE, Ciampa N, Chen Y, et al. Characteristics of Campylobacter and Salmonella infections and acute gastroenteritis in older adults in Australia, Canada, and the United States. Clin Infect Dis. 2019;69(9):1545–52.
Perfect JR, Marr KA, Walsh TJ, et al. Voriconazole treatment for less-common, emerging, or refractory fungal infections. Clin Infect Dis. 2003;36(9):1122–31.
Kuschner RA, Trofa AF, Thomas RJ, et al. Use of azithromycin for the treatment of Campylobacter enteritis in travelers to Thailand, an area where ciprofloxacin resistance is prevalent. Clin Infect Dis. 1995;21(3):536–41.
Nelson EJ, Nelson DS, Salam MA, Sack DA. Antibiotics for both moderate and severe cholera. N Engl J Med. 2011;364(1):5–7.
Thønnings S, Knudsen JD, Schønheyder HC, et al. Antibiotic treatment and mortality in patients with Listeria monocytogenes meningitis or bacteraemia. Clin Microbiol Infect. 2016;22(8):725–30.
Ooi ST, Lorber B. Gastroenteritis due to Listeria monocytogenes. Clin Infect Dis. 2005;40(9):1327–32.
Pappas PG, Kauffman CA, Andes DR, et al. Executive summary: clinical practice guideline for the management of candidiasis: 2016 update by the infectious diseases society of America. Clin Infect Dis. 2016;62(4):409–17.
Goldman M, Cloud GA, Wade KD, et al. A randomized study of the use of fluconazole in continuous versus episodic therapy in patients with advanced HIV infection and a history of oropharyngeal candidiasis: AIDS Clinical Trials Group Study 323/Mycoses Study Group Study 40. Clin Infect Dis. 2005;41(10):1473–80.
Spanakis EK, Aperis G, Mylonakis E. New agents for the treatment of fungal infections: clinical efficacy and gaps in coverage. Clin Infect Dis. 2006;43(8):1060–8.
Wilcox CM, Darouiche RO, Laine L, Moskovitz BL, Mallegol I, Wu J. A randomized, double-blind comparison of itraconazole oral solution and fluconazole tablets in the treatment of esophageal candidiasis. J Infect Dis. 1997;176(1):227–32.
Rossignol JF, Ayoub A, Ayers MS. Treatment of diarrhea caused by Cryptosporidium parvum: a prospective randomized, double-blind, placebo-controlled study of Nitazoxanide. J Infect Dis. 2001;184(1):103–6.
Fox LM, Saravolatz LD. Nitazoxanide: a new thiazolide antiparasitic agent. Clin Infect Dis. 2005;40(8):1173–80.
Smith HV, Corcoran GD. New drugs and treatment for cryptosporidiosis. Curr Opin Infect Dis. 2004;17(6):557–64.
Gandhi MK, Khanna R. Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments. Lancet Infect Dis. 2004;4(12):725–38.
Kotton CN, Kumar D, Caliendo AM. Updated international consensus guidelines on the management of cytomegalovirus in solid organ transplantation. Transplantation. 2013;96(4):333–60
Nih.gov. http://aidsinfo.nih.gov/contentfiles/lvguidelines/adult_oi.pdf. Accessed 1 Dec 2020.
Canalejo E, Durán FG, Cabello N, Martínez JG. Herpes esophagitis in healthy adults and adolescents: report of 3 cases and review of the literature. Medicine (Baltimore). 2010;89(4):204–10.
Shirley D-AT, Farr L, Watanabe K, Moonah S. A review of the global burden, new diagnostics, and current therapeutics for amebiasis. Open Forum Infect Dis. 2018;5(7):ofy161.
Bercu TE, Petri WA, Behm JW. Amebic colitis: new insights into pathogenesis and treatment. Curr Gastroenterol Rep. 2007;9(5):429–33.
Gardner TB, Hill DR. Treatment of giardiasis. Clin Microbiol Rev. 2001;14(1):114–28.
Minetti C, Chalmers RM, Beeching NJ, Probert C, Lamden K. Giardiasis. BMJ. 2016;355:i5369.
Granados CE, Reveiz L, Uribe LG, Criollo CP. Drugs for treating giardiasis. Cochrane Database Syst Rev. 2012;12:CD007787.
Conterno LO, Turchi MD, Corrêa I, Monteiro de Barros Almeida RA. Anthelmintic drugs for treating ascariasis. Cochrane Database Syst Rev. 2020;4:CD010599.
Albanese G, Venturi C, Galbiati G. Treatment of larva migrans cutanea (creeping eruption): a comparison between albendazole and traditional therapy: treatment of larva migrans cutanea. Int J Dermatol. 2001;40(1):67–71.
Steinmann P, Utzinger J, Du Z-W, et al. Efficacy of single-dose and triple-dose albendazole and mebendazole against soil-transmitted helminths and Taenia spp.: a randomized controlled trial. PLoS One. 2011;6(9):e25003.
Palmeirim MS, Hürlimann E, Knopp S, et al. Efficacy and safety of co-administered ivermectin plus albendazole for treating soil-transmitted helminths: a systematic review, meta-analysis and individual patient data analysis. PLoS Negl Trop Dis. 2018;12(4):e0006458.
King CL, Suamani J, Sanuku N, et al. A trial of a triple-drug treatment for lymphatic filariasis. N Engl J Med. 2018;379(19):1801–10.
Mahanty S, Maclean JD, Cross JH. Liver, lung, and intestinal fluke infections. In: Tropical infectious diseases: principles, pathogens and practice. Amsterdam: Elsevier; 2011. p. 854–67.
Liu LX, Harinasuta KT. Liver and intestinal flukes. Gastroenterol Clin N Am. 1996;25(3):627–36.
Shane AL, Mody RK, Crump JA, et al. 2017 infectious diseases society of America clinical practice guidelines for the diagnosis and management of infectious diarrhea. Clin Infect Dis. 2017;65(12):e45–80.
Horton J. Albendazole: a review of anthelmintic efficacy and safety in humans. Parasitology. 2000;121(Suppl):S113–32.
Mellinger JL, Rossaro L, Naugler WE, et al. Epstein-Barr virus (EBV) related acute liver failure: a case series from the US Acute Liver Failure Study Group. Dig Dis Sci. 2014;59(7):1630–7.
Zahid M, Ali N, Saad M, Kelly P, Ortiz A. Acute Cytomegalovirus (CMV) hepatitis in an immunocompetent adult. Am J Case Rep. 2020;21:e925495.
DuPont HL. Azithromycin for the self-treatment of traveler’s diarrhea. Clin Infect Dis. 2007;44(3):347–9.
Leibovici-Weissman Y, Neuberger A, Bitterman R, Sinclair D, Salam MA, Paul M. Antimicrobial drugs for treating cholera. Cochrane Database Syst Rev. 2014;(6):CD008625.
Feldman M, Friedman LS, Brandt LJ. Preface. In: Sleisenger and Fordtran’s gastrointestinal and liver disease. Philadelphia: Elsevier; 2010. p. xix–xx.
Darouiche RO. Oropharyngeal and esophageal candidiasis in immunocompromised patients: treatment issues. Clin Infect Dis. 1998;26(2):259–72; quiz 273–274.
Vazquez JA. Management of oropharyngeal and esophageal candidiasis in patients with HIV infection. HIV Ther. 2010;4(3):325–43.
Deresinski SC, Stevens DA. Caspofungin. Clin Infect Dis. 2003;36(11):1445–57.
Aslam S, Rotstein C, AST Infectious Disease Community of Practice. Candida infections in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019;33(9):e13623.
Jacobson MA. Review of the toxicities of foscarnet. J Acquir Immune Defic Syndr. 1992;5(Suppl 1):S11–7.
Wendt S, Trawinski H, Schubert S, Rodloff AC, Mössner J, Lübbert C. The diagnosis and treatment of pinworm infection. Dtsch Arztebl Int. 2019;116(13):213–19. Lagier JC, Fenollar F, Lepidi H, Giorgi R, Million M, Raoult D. Treatment of classic Whipple’s disease: from in vitro results to clinical outcome. J Antimicrob Chemother. 2013;69(1):219–27. https://doi.org/10.1093/jac/dkt310.
United States Centers for Disease Control and Prevention. Parasites – lymphatic filariasis. http://www.cdc.gov/parasites/lymphaticfilariasis/treatment.html. Accessed on Dec 2020.
World Health Organizaiton. World Health Organizaiton model prescribing information: drugs used in parasitic diseases. 2nd ed. Helminths; 1995.
Drugs for parasitic infections. 3rd ed. New Rochelle: The Medical Letter; 2013.
Bierer DW. Bismuth subsalicylate: history, chemistry, and safety. Rev Infect Dis. 1990;12(Suppl 1):S3–8.
Centers for Disease Control and Prevention (CDC). Parasites – cysticercosis. Centers for Disease Control and Prevention.
Centers for Disease Control and Prevention (CDC). Parasites – clonorchiasis. Centers for Disease Control and Prevention website. https://www.cdc.gov/parasites/clonorchis/health_professionals/index.html. Updated March 1, 2018. Accessed Dec 2020.
HHS Panel on Opportunistic Infections in Adults and Adolescents with HIV. Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV: recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. http://aidsinfo.nih.gov/contentfiles/lvguidelines/adult_oi.pdf. Accessed Nov 2020.
US Department of Health and Human Services (HHS) Panel on Adult and Adolescent Opportunistic Infection. Guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. http://aidsinfo.nih.gov/contentfiles/lvguidelines/adult_oi.pdf. Updated November 21, 2019. Accessed Dec 2020.
Centers for Disease Control and Prevention. DPDx: fascioliasis. https://www.cdc.gov/dpdx/fascioliasis/index.html. Accessed on 29 Nov 2020.
World Health Organizaiton model prescribing information: drugs used in parasitic diseases. 2nd ed. Helminths.
Rezaizadeh H, Olson E. Specific GI infections. In: Wu GY, editor. Pocket handbook of GI pharmacotherapeutics. 2nd ed. Totowa: Humana Press; 2016. p. 100.
Lagier J-C, Fenollar F, Lepidi H, Giorgi R, Million M, Raoult D. Treatment of classic Whipple’s disease: from in vitro results to clinical outcome. J Antimicrob Chemother. 2013;69(1):219–27.
Boulos A, Rolain J-M, Raoult D. Antibiotic susceptibility of tropheryma Whipplei in MRC5 cells. Antimicrob Agents Chemother. 2004;48(3):747–52.
Feurle GE, Junga NS, Marth T. Efficacy of ceftriaxone or meropenem as initial therapies in Whipple’s disease. Gastroenterology. 2010;138(2):478–86.
Clifford McDonald L, Gerding DN, Johnson S, et al. Jurate Ivanaviciene, Julia Kostka based on clinical practice guideline for Clostridium difficile infection in adults and children. 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis. 2018;66:987–94.
Feldman M, et al. Sleisenger & Fordtran gastrointestinal and liver disease. 8th ed. Philadelphia: Saunders; 2006.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Pakala, T. (2021). Specific Gastrointestinal Microbial Infections. In: Mavilia, M.G., Wu, G.Y. (eds) Pocket Handbook of GI Pharmacotherapeutics. Clinical Gastroenterology. Humana, Cham. https://doi.org/10.1007/978-3-030-72592-1_7
Download citation
DOI: https://doi.org/10.1007/978-3-030-72592-1_7
Published:
Publisher Name: Humana, Cham
Print ISBN: 978-3-030-72591-4
Online ISBN: 978-3-030-72592-1
eBook Packages: MedicineMedicine (R0)